Steve Holmes: Stage 4 Cholangiocarcinoma Survivor Story
Steve Holmes survived stage 4 cholangiocarcinoma after surgery, recurrence and immunotherapy. A patient story revealing the biology and decisions behind survival.
NRG1 Fusion Cholangiocarcinoma
Most patients miss pathways like this, not because they don’t qualify, but because rare fusion signals are never fully investigated in time. NRG1 Fusion Cholangiocarcinoma is now linked to a newly FDA-approved targeted therapy called BIZENGRI for patients carrying this rare fusion pathway.
HER2 biliary cancer trial Australia | Early-phase study (NCT05523947)\
A targeted, early-stage HER2 trial opens an option for a small, defined group of biliary cancer patients and requires precise selection and grounded expectations.
Inside Cholangio: Where It Begins
Most patients are told what their cancer is. Very few are shown where it begins. This article places you inside the system where cholangiocarcinoma starts, so you can understand what is happening and respond before options are lost.
Cancer Becomes The Way
It is the origin of a patient-led foundation, community and culture to improve cholangiocarcinoma survival by helping people act early, before options are lost.
Cholangiocarcinoma Survival Pathway | Staying Alive. Staying Yourself.
Five years with stage IV cholangiocarcinoma is rare. But this is not just a survival story. It is a pathway. A sequence of decisions, steps, and actions that others can follow. If you look closely, the structure is there.
Steve Holmes: Stage 4 Cholangiocarcinoma Survivor Story
Steve Holmes survived stage 4 cholangiocarcinoma after surgery, recurrence and immunotherapy. A patient story revealing the biology and decisions behind survival.
NRG1 Fusion Cholangiocarcinoma
Most patients miss pathways like this, not because they don’t qualify, but because rare fusion signals are never fully investigated in time. NRG1 Fusion Cholangiocarcinoma is now linked to a newly FDA-approved targeted therapy called BIZENGRI for patients carrying this rare fusion pathway.
HER2 biliary cancer trial Australia | Early-phase study (NCT05523947)\
A targeted, early-stage HER2 trial opens an option for a small, defined group of biliary cancer patients and requires precise selection and grounded expectations.
Inside Cholangio: Where It Begins
Most patients are told what their cancer is. Very few are shown where it begins. This article places you inside the system where cholangiocarcinoma starts, so you can understand what is happening and respond before options are lost.
Cancer Becomes The Way
It is the origin of a patient-led foundation, community and culture to improve cholangiocarcinoma survival by helping people act early, before options are lost.
Cholangiocarcinoma Survival Pathway | Staying Alive. Staying Yourself.
Five years with stage IV cholangiocarcinoma is rare. But this is not just a survival story. It is a pathway. A sequence of decisions, steps, and actions that others can follow. If you look closely, the structure is there.
